A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT06859762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL217 in Patients With Advanced Solid Tumors
Study identification
- NCT ID
- NCT06859762
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Interventions
- YL217 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
- Last update posted
- Jan 13, 2026
2025 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | Recruiting |
| UCLA Hematology/Oncology - Santa Monica | Santa Monica | California | 90404 | Recruiting |
| Yale Cancer Center | New Haven | Connecticut | 06519 | Recruiting |
| The University of Kansas Cancer Center (KUCC) | Kansas City | Kansas | 66205 | Recruiting |
| University of Maryland Medical Center-Greenebaum Cancer Ctr - Medical Oncology | Baltimore | Maryland | 21201 | Not yet recruiting |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | Recruiting |
| Columbia University Irving Medical Center | New York | New York | 10032 | Recruiting |
| Duke University Medical Center (DUMC) | Durham | North Carolina | 27710 | Recruiting |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | Recruiting |
| Cleveland Clinic Taussig Cancer Institute | Cleveland | Ohio | 44195 | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| UT Health San Antonio - Mays Cancer Center | San Antonio | Texas | 78229 | Recruiting |
| University of Wisconsin Health - UW Carbone Cancer Center | Madison | Wisconsin | 53792 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06859762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06859762 live on ClinicalTrials.gov.